IMPORTANCE: Screening colonoscopy seemingly decreases colorectal cancer rates in the United States. In addition to removing benign lesions and preventing progression to malignancy, screening colonoscopy theoretically identifies asymptomatic patients with early-stage disease, potentially leading to higher survival rates. OBJECTIVES: To assess the effect of screening colonoscopy on outcomes of colon cancer surgery by reviewing differences in staging, disease-free interval, risk of recurrence, and survival and to identify whether diagnosis through screening improves long-term outcomes independent of staging. DESIGN: Retrospective review of prospectively maintained, institutional review board-approved database. SETTING: Tertiary care center with high patient volume. PATIENTS: All patients who underwent colon cancer surgery at Massachusetts General Hospital from January 1, 2004, through December 31, 2011. INTERVENTION: Colon cancer surgery. MAIN OUTCOMES AND MEASURES: Postoperative staging, death, and recurrence, measured as incidence and time to event. RESULTS: A total of 1071 patients were included, with 217 diagnosed through screening. Patients not diagnosed through screening were at risk for a more invasive tumor (≥T3: relative risk [RR] = 1.96; P < .001), nodal disease (RR = 1.92; P < .001), and metastatic disease on presentation (RR = 3.37; P < .001). In follow-up, these patients had higher death rates (RR = 3.02; P < .001) and recurrence rates (RR = 2.19; P = .004) as well as shorter survival (P < .001) and disease-free intervals (P < .001). Cox and logistic regression controlling for staging and baseline characteristics revealed that death rate (P = .02) and survival duration (P = .01) were better stage for stage with diagnosis through screening. Death and metastasis rates also remained significantly lower in tumors without nodal or metastatic spread (all P < .001). CONCLUSIONS AND RELEVANCE: Patients with colon cancer identified on screening colonoscopy not only have lower-stage disease on presentation but also have better outcomes independent of their staging. Compliance to screening colonoscopy guidelines can play an important role in prolonging longevity, improving quality of life, and reducing health care costs through early detection of colon cancer.
IMPORTANCE: Screening colonoscopy seemingly decreases colorectal cancer rates in the United States. In addition to removing benign lesions and preventing progression to malignancy, screening colonoscopy theoretically identifies asymptomatic patients with early-stage disease, potentially leading to higher survival rates. OBJECTIVES: To assess the effect of screening colonoscopy on outcomes of colon cancer surgery by reviewing differences in staging, disease-free interval, risk of recurrence, and survival and to identify whether diagnosis through screening improves long-term outcomes independent of staging. DESIGN: Retrospective review of prospectively maintained, institutional review board-approved database. SETTING: Tertiary care center with high patient volume. PATIENTS: All patients who underwent colon cancer surgery at Massachusetts General Hospital from January 1, 2004, through December 31, 2011. INTERVENTION: Colon cancer surgery. MAIN OUTCOMES AND MEASURES: Postoperative staging, death, and recurrence, measured as incidence and time to event. RESULTS: A total of 1071 patients were included, with 217 diagnosed through screening. Patients not diagnosed through screening were at risk for a more invasive tumor (≥T3: relative risk [RR] = 1.96; P < .001), nodal disease (RR = 1.92; P < .001), and metastatic disease on presentation (RR = 3.37; P < .001). In follow-up, these patients had higher death rates (RR = 3.02; P < .001) and recurrence rates (RR = 2.19; P = .004) as well as shorter survival (P < .001) and disease-free intervals (P < .001). Cox and logistic regression controlling for staging and baseline characteristics revealed that death rate (P = .02) and survival duration (P = .01) were better stage for stage with diagnosis through screening. Death and metastasis rates also remained significantly lower in tumors without nodal or metastatic spread (all P < .001). CONCLUSIONS AND RELEVANCE: Patients with colon cancer identified on screening colonoscopy not only have lower-stage disease on presentation but also have better outcomes independent of their staging. Compliance to screening colonoscopy guidelines can play an important role in prolonging longevity, improving quality of life, and reducing health care costs through early detection of colon cancer.
Authors: Stephanie B Wheeler; Jennifer Leeman; Kristen Hassmiller Lich; Florence K L Tangka; Melinda M Davis; Lisa C Richardson Journal: Cancer J Date: 2018 May/Jun Impact factor: 3.360
Authors: Lieve G J Leijssen; Anne M Dinaux; Hiroko Kunitake; Liliana G Bordeianou; David L Berger Journal: Surg Endosc Date: 2019-04-24 Impact factor: 4.584
Authors: Quinton M Hatch; Kevin R Kniery; Eric K Johnson; Shelly A Flores; David L Moeil; John J Thompson; Justin A Maykel; Scott R Steele Journal: J Gastrointest Surg Date: 2015-12-01 Impact factor: 3.452
Authors: Michael P M de Neree Tot Babberich; Nina C A Vermeer; Michel W J M Wouters; Wilhelmina M U van Grevenstein; Koen C M J Peeters; Evelien Dekker; Pieter J Tanis Journal: JAMA Surg Date: 2018-12-19 Impact factor: 14.766
Authors: Ajith K Siriwardena; James M Mason; Saifee Mullamitha; Helen C Hancock; Santhalingam Jegatheeswaran Journal: Nat Rev Clin Oncol Date: 2014-06-03 Impact factor: 66.675